Adicet Bio Files Q1 2025 10-Q, Details Financials
Ticker: ACET · Form: 10-Q · Filed: May 6, 2025 · CIK: 1720580
| Field | Detail |
|---|---|
| Company | Adicet Bio, Inc. (ACET) |
| Form Type | 10-Q |
| Filed Date | May 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
Adicet Bio's Q1 2025 10-Q is in: financials updated, asset values detailed.
AI Summary
Adicet Bio, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly resTORbio, Inc., is focused on pharmaceutical preparations. Key financial data and fair value measurements for assets like money market funds and U.S. Treasury securities are detailed, with reporting dates including December 31, 2024, and March 31, 2025.
Why It Matters
This filing provides investors with an update on Adicet Bio's financial position and asset valuations as of the first quarter of 2025, crucial for understanding the company's stability and investment potential.
Risk Assessment
Risk Level: medium — The filing is a standard quarterly report, but the pharmaceutical industry carries inherent risks related to drug development and regulatory approval.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial information is reported.)
- 2025-05-06 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)
- 2024-12-31 — Prior Period End Date (Represents the end of the previous fiscal year, used for comparative financial analysis.)
Key Players & Entities
- Adicet Bio, Inc. (company) — Filer of the 10-Q
- resTORbio, Inc. (company) — Former name of Adicet Bio, Inc.
- 20250331 (date) — End of reporting period
- 20250506 (date) — Filing date
- 001-38359 (dollar_amount) — SEC File Number
FAQ
What is the primary business of Adicet Bio, Inc.?
Adicet Bio, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code [2834].
What was Adicet Bio, Inc. formerly known as?
Adicet Bio, Inc. was formerly known as resTORbio, Inc., with a date of name change on October 24, 2017.
What is the SEC file number for Adicet Bio, Inc.?
The SEC file number for Adicet Bio, Inc. is 001-38359.
What types of financial assets are mentioned in the filing regarding fair value measurements?
The filing mentions fair value measurements for assets including Money Market Funds and U.S. Treasury Securities.
What are the reporting dates for the financial data presented in this 10-Q?
The financial data presented in this 10-Q pertains to the period ending March 31, 2025, with comparative data for December 31, 2024.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 6, 2025 regarding Adicet Bio, Inc. (ACET).